Author
Listed:
- Jan Remsik
(Memorial Sloan Kettering Cancer Center
VIB
KU Leuven)
- Xinran Tong
(Memorial Sloan Kettering Cancer Center
Weill Cornell Medicine)
- Russell Z. Kunes
(Memorial Sloan Kettering Cancer Center
Columbia University)
- Min Jun Li
(Memorial Sloan Kettering Cancer Center
University of California San Diego)
- Rachel Estrera
(Memorial Sloan Kettering Cancer Center)
- Jenna Snyder
(Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center)
- Clark Thomson
(Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center)
- Ahmed M. Osman
(Memorial Sloan Kettering Cancer Center
Karolinska Institutet)
- Kiana Chabot
(Memorial Sloan Kettering Cancer Center
New York Institute of Technology)
- Ugur T. Sener
(Memorial Sloan Kettering Cancer Center
Mayo Clinic)
- Jessica A. Wilcox
(Memorial Sloan Kettering Cancer Center)
- Danielle Isakov
(Memorial Sloan Kettering Cancer Center
Weill Cornell Medicine)
- Helen Wang
(Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center)
- Tejus A. Bale
(Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center)
- Ronan Chaligné
(Memorial Sloan Kettering Cancer Center)
- Joseph C. Sun
(Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center)
- Chrysothemis Brown
(Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College)
- Dana Pe’er
(Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center)
- Adrienne Boire
(Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center)
Abstract
Metastasis to the cerebrospinal-fluid-filled leptomeninges, or leptomeningeal metastasis, represents a fatal complication of solid tumours1. Multimodal analyses of clinical specimens reveal substantial inflammatory infiltrate in leptomeningeal metastases with enrichment of IFNγ and resulting downstream signalling. Here, to investigate and overcome this futile anti-tumour response within the leptomeninges, we developed syngeneic lung cancer, breast cancer and melanoma leptomeningeal-metastasis mouse models. We show that transgenic host mice lacking IFNγ or its receptor fail to control the growth of leptomeningeal metastases growth. Leptomeningeal overexpression of Ifng through a targeted adeno-associated-virus-based system controls cancer cell growth independent of adaptive immunity. Using a suite of transgenic hosts, we demonstrate that leptomeningeal T cells generate IFNγ to actively recruit and activate peripheral myeloid cells, generating a diverse spectrum of dendritic cell subsets. Independent of antigen presentation, migratory CCR7+ dendritic cells orchestrate the influx, proliferation and cytotoxic action of natural killer cells to control cancer cell growth in the leptomeninges. This study identifies unique, leptomeninges-specific IFNγ signalling and suggests an immune-therapeutic approach against tumours within this space.
Suggested Citation
Jan Remsik & Xinran Tong & Russell Z. Kunes & Min Jun Li & Rachel Estrera & Jenna Snyder & Clark Thomson & Ahmed M. Osman & Kiana Chabot & Ugur T. Sener & Jessica A. Wilcox & Danielle Isakov & Helen W, 2025.
"Interferon-γ orchestrates leptomeningeal anti-tumour response,"
Nature, Nature, vol. 643(8073), pages 1087-1096, July.
Handle:
RePEc:nat:nature:v:643:y:2025:i:8073:d:10.1038_s41586-025-09012-z
DOI: 10.1038/s41586-025-09012-z
Download full text from publisher
As the access to this document is restricted, you may want to
for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:643:y:2025:i:8073:d:10.1038_s41586-025-09012-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.